(Q72924065)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8371917%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

title

Intraocular pressure-reducing effect of PhXA41 in patients with increased eye pressure. A one-month study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8371917%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

author name string

A Alm

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8371917%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

J Villumsen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8371917%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

P Törnquist

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8371917%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

A Mandahl

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8371917%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

J Airaksinen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8371917%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

A Tuulonen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8371917%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

A Marsk

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8371917%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

B Resul

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8371917%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

J Stjernschantz

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8371917%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

publication date

1 September 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8371917%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8371917%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

volume

100

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8371917%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8371917%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

page(s)

1312-6; discussion 1316-7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8371917%20AND%20SRC:MED&resulttype=core&format=json

The effects of prostaglandin F2 alpha in the human eye

30 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2893%2931482-X

7 January 2021

Prostaglandin F2 alpha-1-isopropylester lowers intraocular pressure without decreasing aqueous humor flow

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2893%2931482-X

7 January 2021

Prostaglandin F2 alpha-isopropylester eye drops: effects in normal human eyes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2893%2931482-X

7 January 2021

Prostaglandin F2 alpha-isopropylester eye drops: effect on intraocular pressure in open-angle glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2893%2931482-X

7 January 2021

The effect of adding prostaglandin F2 alpha-isopropylester to timolol in patients with open angle glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2893%2931482-X

7 January 2021

Additivity of prostaglandin F2 alpha-1-isopropyl ester to timolol in glaucoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2893%2931482-X

7 January 2021

Ocular effects of two different prostaglandin F2 alpha esters. A doublemasked cross-over study on normotensive eyes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2893%2931482-X

7 January 2021

Phenyl-substituted prostaglandins: potent and selective antiglaucoma agents

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2893%2931482-X

7 January 2021

PhXA34, a new potent ocular hypotensive drug. A study on dose-response relationship and on aqueous humor dynamics in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2893%2931482-X

7 January 2021

PhXA34--a prostaglandin F2 alpha analogue. Effect on intraocular pressure in patients with ocular hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2893%2931482-X

7 January 2021

Intraocular pressure reduction with PhXA34, a new prostaglandin analogue, in patients with ocular hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2893%2931482-X

7 January 2021

Shortterm “escape” and longterm “drift.”. The dissipation effects of the beta adrenergic blocking agents

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2893%2931482-X

7 January 2021

Effects of PhXA41, a new prostaglandin F2 alpha analog, on aqueous humor dynamics in human eyes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2893%2931482-X

7 January 2021

Intraocular pressure-reducing effect of PhXA41 in ocular hypertension. Comparison of dose regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2893%2931482-X

7 January 2021

10.1016/S0161-6420(93)31482-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8371917%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

1 reference